5th Biomarker Discovery & Development

The rapid evolution of translational medicine has pushed biomarkers into the spotlight into the discovery and development of the next generation therapeutics and diagnostics. With many top tier pharmaceutical and diagnostic organizations – including Novartis, Hoffmann-La Roche, Pfizer, Bayer, and Bristol Myers Squibb, fully integrating these strategies into their product development pipelines, it clearly demonstrates how biomarkers are the future of medicine. The biomarker market is expected to eclipse $12.8 billion dollars by the year 2012. Due to the obvious clinical and commercial importance, we must develop a full understanding of biomarker versatility and limitations, while staying abreast of the undercurrents in this evolving field.

GTC’s 5th Annual Biomarker Discovery and Development Conference held on October 19-21, 2011 at the Paradise Point Resort & Spa in San Diego, CA will present you a host of distinguished speakers, who will address topics that span the past, present and future of biomarker research. By taking a comprehensive look at the progress that has already been made, we will be able to make projections into the future regarding the ultimate development of personalized medicine. The discussions will begin with an overview of novel technologies used in biomarker discovery, followed by how these approaches are being utilized to streamline the development process by reducing time and costs, as well as minimizing drug attrition associated with safety concerns. The discussions will then culminate with topics including biomarker utility and clinical trials as companion diagnostics in the clinics.

In order to maximize your productivity in this field, be sure that you and your organization have a solid foundation! GTC’s Biomarker Conference series have consistently delivered the full picture as well as a quality environment to share and gain powerful knowledge and insight into cutting edge research. Come join your colleagues in this timely conference and rediscover biomarkers!

Full info at: 5th Biomarker Discovery & Development.

Leave a Reply